Skip to main content
. 2017 Jul 8;19(8):1613–1627. doi: 10.1093/pm/pnx151

Figure 2.

Figure 2

Prevalence of abuse of crush-resistant tablets (CRTs) and non-CRTs for all oral modes of administration (MOAs) among any respondents who abuse the product. *Difference between CRT and non-CRT significant at P < 0.0001. Note: The denominator for each drug category is all individuals who abused at least one of the products included in the category (see Table 1 and Figure 1). The numerator is individuals who abused the product by the MOA. CI = confidence interval; CRT = crush-resistant tablet.